OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services, today announces its DNA Genotek subsidiary has received Emergency Use Authorization (EUA) from the U.S. Fooda and Drug Administration (FDA) for the use of DNA Genotek’s OMNIgene® ORAL (OM-505, OME-505) saliva collection and stabilization device in COVID-19 testing.

The COVID-19 test that’s been used for extensive testing of SUNY students now has the go-ahead for use on a wider scale.

A sewage testing process developed in Syracuse helped SUNY Oneonta put the brakes on a coronavirus outbreak in August that infected more than 700 students.

OraSure Technologies, Inc., a leader in point-of-care diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services, today announced that its ORAcollect® RNA (OR-100) saliva collectin device has been included in the U.S. Food and Drug Administration (FDA) Emergency Use Authorization (EUA) granted to Quadrant Biosciences Inc. for a COVID-19 laboratory test.

Governor Andre M. Cuomo and State University of New York Chancellor Jim Malatras today announced that the individual saliva swab diagnostic test for COVID-19 developed by SUNY Upstate Medica and Quadrant Biosciences has been granted emergency use authorization by the U.S. Food and Drug Administration.

Students attending the State University of New York’s 64 campuses could be tested for the coronavirus as often as every two weeks to prevent outbreaks of the killer bug, officials said Friday.

A rapid test designed to use a patient’s saliva to diagnose cases of COVID-19 is now available for use on SUNY campuses.

Governor Andre M. Cuomo and State University of New York Chancellor Jim Malatras today announced that the individual saliva swab diagnostic test for COVID-19 developed by SUNY Upstate Medica and Quadrant Biosciences has been granted emergency use authorization by the U.S. Food and Drug Administration.

Governor Andrew M. Cuomo today announced a series of new initiatives related to COVID-19 testing that will improve New York State’s ability to detect and control the virus in communities across the state.

Game-changing approach will help inform decision-making, protect public health in Albany, Buffalo and Syracuse

Game-changing approach will help inform decision-making, protect public health in upstate communities.

Traditionally, children who are thought to have autism are put through a series of practical tests. About one in 59 children are diagnosed with Autism Spectrum Disorder in the United States, according to the CDC.

A saliva test designed to quickly diagnose autism in toddlers has hit the market after seven years of research at SUNY Upstate Medical University and Penn State.

A saliva test to detect oral microbes may offer an accurate way of detecting Parkinson’s in its early stages and further understanding of the disease, a study reports.

Quadrant Biosciences Inc. has been awarded the Technology Business of the Year by the New York State Small Business Development Center (SBDC).

Scientists have discovered certain molecules in the saliva that not only differentiate children with autism spectrum disorder (ASD), but appear to correlate with specific autism traits.